ERBB2 and triple-negative breast carcinoma: This cell line represents a highly aggressive, invasive, and poorly differentiated triple-negative breast cancer cell line, as it lacks estrogen receptor (ER) and progesterone receptor (PR) expression, as well as HER2 (human epidermal growth factor receptor 2) amplification.